{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:47:10Z","timestamp":1787010430285,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1097\/tp.0000000000001691","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T07:44:30Z","timestamp":1487835870000},"page":"S41-S43","source":"Crossref","is-referenced-by-count":25,"title":["mTOR Inhibition and Cardiovascular Diseases"],"prefix":"10.1097","volume":"102","author":[{"given":"Ernesto","family":"Paoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","article-title":"Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia","volume":"14","author":"Rigatto","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ Res"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ki.2008.690","article-title":"Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure","volume":"75","author":"Siedlecki","year":"2009","journal-title":"Kidney Int"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ajkd.2008.04.018","article-title":"Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: a 1-year nonrandomized controlled trial","volume":"52","author":"Paoletti","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/TP.0b013e318189049a","article-title":"Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft","volume":"86","author":"Raichlin","year":"2008","journal-title":"Transplantation"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/TP.0b013e318242be28","article-title":"Effect of everolimus on left ventricular hypertrophy of de novo kidney transplant recipients: a 1 year, randomized, controlled trial","volume":"93","author":"Paoletti","year":"2012","journal-title":"Transplantation"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TP.0b013e3182a92728","article-title":"Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the Randomized Controlled CENTRAL Trial","volume":"97","author":"Murbraech","year":"2014","journal-title":"Transplantation"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/ctr.12565","article-title":"Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients\u2013a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial","volume":"29","author":"Murbraech","year":"2015","journal-title":"Clin Transplant"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2369-15-65","article-title":"Regression of cardiac growth in kidney transplant recipients using anti-m-TOR drugs plus RAS blockers: a controlled longitudinal study","volume":"15","author":"Hern\u00e1ndez","year":"2014","journal-title":"BMC Nephrol"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/tri.12862","article-title":"Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation","volume":"29","author":"Cruzado","year":"2016","journal-title":"Transpl Int"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/01.hjh.0000239304.01496.83","article-title":"Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis","volume":"24","author":"Gao","year":"2006","journal-title":"J Hypertens"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/ndt\/gfv354","article-title":"Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study","volume":"31","author":"Paoletti","year":"2016","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:27:54Z","timestamp":1620962874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201802001-00008"}},"subtitle":["Cardiac Hypertrophy"],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":12,"journal-issue":{"issue":"2S","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001691","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}